Literature DB >> 30064691

Does Low FEV1 in Addition to Fixed Ratio and/or Lower Limit of Normal of FEV1/FVC Improve Prediction of Mortality in COPD? The NHANES-III-linked-mortality Cohort.

Yewande E Odeyemi1, O'Dene Lewis2, Julius Ngwa3, Kristen Dodd4, Richard F Gillum5, Alem Mehari1.   

Abstract

PURPOSE: There is presently an ongoing debate on the relative merits of suggested criteria for spirometric airway obstruction. This study tests the null hypothesis that no superiority exists with the use of fixed ratio (FR) of forced expiratory volume in the first second (FEV1)/forced vital capacity (FVC) < 0.7 versus less than lower limit predicted (LLN) criteria with or without FEV1 <80% predicted in regards to future mortality.
METHODS: In 1988-1994 the Third National Health and Nutrition Examination Survey (NHANES III) measured FEV1 and FVC with mortality follow-up data through December 31, 2011. For this survival analysis 7472 persons aged 40 and over with complete data formed the analytic sample.
RESULTS: There were a total of 3554 deaths. Weighted Cox proportional hazards regression revealed an increased hazard ratio in persons with both fixed ratio and lower limit of normal with a low FEV1 (1.79, p < 0.0001), in those with fixed ratio only with a low FEV1 (1.77, p < 0.0001), in those with abnormal fixed ratio only with a normal FEV1 (1.28, p < 0.0001) compared with persons with no airflow obstruction (reference group). These remained significant after adjusting for demographic variables and other confounding variables.
CONCLUSIONS: The addition of FEV1 < 80% of predicted increased the prognostic power of the fixed ratio <0.7 and/or below the lower limit of predicted criteria for airway obstruction.
Copyright © 2019 National Medical Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic obstructive; Mortality; Pulmonary disease; Spirometry; Survival analysis

Year:  2018        PMID: 30064691      PMCID: PMC6349529          DOI: 10.1016/j.jnma.2018.06.006

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  13 in total

1.  Chronic obstructive pulmonary disease among adults aged 18 and over in the United States, 1998-2009.

Authors:  Lara J Akinbami; Xiang Liu
Journal:  NCHS Data Brief       Date:  2011-06

2.  Obstructive and restrictive lung disease and functional limitation: data from the Third National Health and Nutrition Examination.

Authors:  D M Mannino; E S Ford; S C Redd
Journal:  J Intern Med       Date:  2003-12       Impact factor: 8.989

3.  Acceptability and reproducibility criteria of the American Thoracic Society as observed in a sample of the general population.

Authors:  J L Hankinson; K M Bang
Journal:  Am Rev Respir Dis       Date:  1991-03

4.  Clinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohort.

Authors:  Wouter van Dijk; Wan Tan; Pei Li; Best Guo; Summer Li; Andrea Benedetti; Jean Bourbeau
Journal:  Ann Fam Med       Date:  2015 Jan-Feb       Impact factor: 5.166

Review 5.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

Authors:  Jørgen Vestbo; Suzanne S Hurd; Alvar G Agustí; Paul W Jones; Claus Vogelmeier; Antonio Anzueto; Peter J Barnes; Leonardo M Fabbri; Fernando J Martinez; Masaharu Nishimura; Robert A Stockley; Don D Sin; Roberto Rodriguez-Roisin
Journal:  Am J Respir Crit Care Med       Date:  2012-08-09       Impact factor: 21.405

6.  Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function?

Authors:  David M Mannino; A Sonia Buist; William M Vollmer
Journal:  Thorax       Date:  2006-11-07       Impact factor: 9.139

7.  Chronic respiratory disease, comorbid cardiovascular disease and mortality in a representative adult US cohort.

Authors:  David M Mannino; Kourtney J Davis; Rachael L Disantostefano
Journal:  Respirology       Date:  2013-10       Impact factor: 6.424

8.  Undiagnosed Obstructive Lung Disease in the United States. Associated Factors and Long-term Mortality.

Authors:  Carlos H Martinez; David M Mannino; Fabian A Jaimes; Jeffrey L Curtis; MeiLan K Han; Nadia N Hansel; Alejandro A Diaz
Journal:  Ann Am Thorac Soc       Date:  2015-12

Review 9.  Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.

Authors:  Rosa Faner; Mauricio Rojas; William Macnee; Alvar Agustí
Journal:  Am J Respir Crit Care Med       Date:  2012-05-10       Impact factor: 21.405

10.  Life expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III Follow-up Study.

Authors:  Robert M Shavelle; David R Paculdo; Scott J Kush; David M Mannino; David J Strauss
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-04-15
View more
  1 in total

1.  Fixed Ratio versus Lower Limit of Normality for Diagnosing COPD in Primary Care: Long-Term Follow-Up of EGARPOC Study.

Authors:  Montserrat Llordés; Angeles Jaen; Elba Zurdo; Montserrat Roca; Inmaculada Vazquez; Pere Almagro
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-06-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.